These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12843573)

  • 1. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
    Ohtsuki S; Hori S; Terasaki T
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
    Ohtsuki S
    Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
    Ohtsuki S
    Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
    Ohtsuki S; Asaba H; Takanaga H; Deguchi T; Hosoya K; Otagiri M; Terasaki T
    J Neurochem; 2002 Oct; 83(1):57-66. PubMed ID: 12358729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABC transporters and drug efflux at the blood-brain barrier.
    Shen S; Zhang W
    Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
    Ohtsuki S; Terasaki T
    Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier transporters and response to CNS-active drugs.
    Urquhart BL; Kim RB
    Eur J Clin Pharmacol; 2009 Nov; 65(11):1063-70. PubMed ID: 19727692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Membrane Transporters and Their Regulatory Mechanisms at the Brain and Retinal Barriers to Establish Therapies for Refractory Central Nervous System Diseases].
    Akanuma SI
    Yakugaku Zasshi; 2020; 140(10):1235-1242. PubMed ID: 32999202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
    Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
    Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transporter-mediated permeation of drugs across the blood-brain barrier.
    Tamai I; Tsuji A
    J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.
    Römermann K; Fedrowitz M; Hampel P; Kaczmarek E; Töllner K; Erker T; Sweet DH; Löscher W
    Neuropharmacology; 2017 May; 117():182-194. PubMed ID: 28192112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
    Tachikawa M; Uchida Y; Terasaki T
    Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.
    Li L; Agarwal S; Elmquist WF
    Drug Metab Dispos; 2013 Mar; 41(3):659-67. PubMed ID: 23297298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
    Löscher W; Potschka H
    NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier efflux transport.
    Golden PL; Pollack GM
    J Pharm Sci; 2003 Sep; 92(9):1739-53. PubMed ID: 12949994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells.
    Mori S; Takanaga H; Ohtsuki S; Deguchi T; Kang YS; Hosoya K; Terasaki T
    J Cereb Blood Flow Metab; 2003 Apr; 23(4):432-40. PubMed ID: 12679720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline.
    Takanaga H; Tokuda N; Ohtsuki S; Hosoya K; Terasaki T
    Mol Pharmacol; 2002 Jun; 61(6):1289-96. PubMed ID: 12021389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.